The new company aims to combine with a healthcare or technology business that can be grown both organically and through strategic transactions. CF V is led by Chairman and CEO Howard W. Lutnick, President Anshu Jain and CFO Alice Chan.
Total SPAC deal count for 2021 year-to-date is now 84 with $23.6 billion in gross proceeds raised. This offering is expected to close on Tuesday, February 2.
Cantor Fitzgerald & Co. is acting as the sole book-running manager for the offering. Ellenoff Grossman & Schole LLP is serving as Issuer’s Counsel with Graubard Miller serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.